ArticleOPEN ACCESS

Gene therapy to inhibit CaMKII in CPVT

Nature Reviews Cardiology
DOI: 10.1038/s41569-019-0226-x
3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cardiomyocyte-selective gene therapy to inhibit calcium/calmodulin-dependent protein kinase II effectively suppresses ventricular arrhythmias in mice with mutations known to cause catecholaminergic polymorphic ventricular tachycardia.

Cite

CITATION STYLE

APA

Lim, G. B. (2019, August 1). Gene therapy to inhibit CaMKII in CPVT. Nature Reviews Cardiology. Nature Publishing Group. https://doi.org/10.1038/s41569-019-0226-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free